Therapeutic action of cannabinoids in a murine model of multiple sclerosis

Journal of Neuroscience

Volumn 23, Issue 7, 2003, Pages 2511-2516

  Arévalo Martín, Ángel ^a   Vela, José Miguel ^b   Molina Holgado, Eduardo ^a   Borrell, José ^a   Guaza, Carmen ^a  

^a INSTITUTO CAJAL   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

CB1 agonists; CB2 agonists; Demyelination; Neuroinflammation; Remyelination; Rotarod; Spinal cord; Theiler's virus

Indexed keywords

2 METHYL 3 (1 NAPHTHOYL) 1 PROPYLINDOLE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; ANANDAMIDE; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR AGONIST; CD4 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ACTIVATION; CELL INFILTRATION; CONTROLLED STUDY; DEMYELINATING DISEASE; DISEASE MODEL; DRUG RECEPTOR BINDING; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LOCOMOTION; MICROGLIA; MOTOR PERFORMANCE; MOUSE; MOUSE STRAIN; MULTIPLE SCLEROSIS; MURINE ENCEPHALOMYELITIS VIRUS; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; REMYELINIZATION; T LYMPHOCYTE SUBPOPULATION;

EID: 17144462251     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.23-07-02511.2003     Document Type: Article

References (39)

1. Baker D, Pryce G, Croxford JL, Brown P, Pertwee RG, Huffman JW, Layward L (2000) Cannabinoids control spasticity and tremor in a multiple sclerosis model. Nature 404:84-87.
2. Baker D, Pryce G, Croxford JL, Brown P, Pertwee RG, Makriyannis A, Khanolkar A, Layward L, Fezza F, Bisogno T, Di Marzo V (2001) Endocannabinoids control spasticity in a multiple sclerosis model. FASEB J 15:300-302.
3. Barna BP, Chou SM, Jacobs B, Yen-Lieberman B, Ransohoff RM (1989) Interferon-β impairs induction of HLA-DR antigen expression in cultured human astrocytes. J Neuroimmunol 23:45-53.
4. Berrendero F, Sanchez A, Cabranes A, Puerta C, Ramos JA, García-Merino A, Fernández Ruiz JJ (2001) Changes in cannabinoid CB1 receptors in striatal and cortical regions of rat with experimental allergic encephalomyelitis, an animal model of multiple sclerosis. Synapse 41:195-202.
5. Bouaboula M, Rinaldi M, Carayon P, Carillon C, Delpech B, Shire D, Le Fur G, Casellas P (1993) Cannabinoid-receptor expression in human leukocytes. Eur J Biochem 214:173-180.
6. Dal Canto MC, Lipton HL (1977) Multiple sclerosis-animal model: Theiler's virus infection in mice. Am J Pathol 88:497-500.
7. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etingen A, Mechoulam R (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258:1946-1949.
8. Di Marzo V, Bifulco M, De Petrocellis L (2000) Endocannabinoids and multiple sclerosis: a blessing from the inner bliss? Trends Pharmacol Sci 21:195-197.
9. Di Marzo V, Bisogno T, De Petrocellis L (2001) Anandamide: some like it hot. Trends Pharmacol Sci 22:346-349.
10. 2-microglobulin-deficient mice. J Virol 67:589-592.
11. Franklin RJ (2002) Why does remyelination fail in multiple sclerosis? Nat Neurosci 3:705-714.
12. Friedmann A, Frankel G, Lorch Y, Steinman L (1987) Monoclonal anti-I-A antibody reverses chronic paralysis and demyelination in Theiler's virusinfected mice: critical importance of timing of treatment. J Virol 61:898-903.
13. Galiegue S, Mary S, Marchand J, Dussossoy D, Carriere D, Carayon P (1995) Expression of central and cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem 232:54-61.
14. Herkenham M, Lynn AB, Little MD, Johson MR, Melvin LS, de Costa BR, Rice KC (1990) Cannabinoid receptor localization in brain. Proc Natl Acad Sci USA 87:1932-1936.
15. Johnson RT (1994) The virology of demyelinating diseases. Ann Neurol 36:54-60.
16. Katz-Levy Y, Neville KL, Girvin AM, Vanderlugt CL, Pope JG, Tan LJ, Miller SD (1999) Endogenous presentation of self myelin epitopes by CNSresident APCs in Theiler's virus-infected mice. J Clin Invest 104:599-610.
17. Klein TW, Lane B, Newton C, Friedman H (2000) Cannabinoid receptors and immunity. Proc Soc Exp Biol Med 225:1-8.
18. Lledó A, Borrell J, Guaza C (1999) Dexamethasone regulation of interleukin-1-receptors in the hippocampus of Theiler's virus-infected mice: effects on virus-mediated demyelination. Eur J Pharmacol 372:75-83.
19. 9tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis. J Neuroimmunol 23:73-81.
20. Malfait AM, Gallily R, Sumariwalla PF, Malik AS, Andreakos E, Mechoulam R, Feldmann M (2000) The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. Proc Natl Acad Sci USA 97:9561-9566.
21. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561-564.
22. McCoy KL, Matmeyeva M, Carlisle SJ, Cabral GA (1999) Cannabinoid inhibition of the processing of intact lysozyme by macrophages: evidence for CB2 receptor participation. J Pharmacol Exp Ther 289:1620-1625.
23. McGavern DB, Zoecklein L, Drescher KM, Rodriguez M (1999) Quantitative assessment of neurologic deficits in a chronic progressive murine model of CNS demyelination. Exp Neurol 158:171-181.
24. McGavern DB, Murray PD, Rivera-Quiñones C, Schmelzer JD, Low PA, Rodriguez M (2000) Axonal loss results in spinal cord atrophy, electrophysiological abnormalities and neurological deficits following demyelination in a chronic inflammatory model of multiple sclerosis. Brain 123:519-531.
25. Mechoulam R, Ben Shabat S, Hanus L, Ligumsky M, Kaminski NE, Shatz AR, Gopher A, Almog S, Martin BR, Compton DR, Pertwee RG, Griffin G, Bayewitch M, Barg J, Vogel Z (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50:83-90.
26. Merril JE, Benveniste EN (1996) Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurosci 19:331-338.
27. Miller SD, Vanderlugt CL, Begolka WS, Pao W, Yauch RL, Neville KL, KatzLevy Y, Carrizosa A, Kim BS (1997) Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat Med 3:1133-1136.
28. Molina-Holgado E, Vela JM, Arévalo-Martín A, Guaza C (2001) LPS/IFN-γ cytotoxicity in oligodendroglial cells: role of nitric oxide and protection by the anti-inflammatory cytokine IL-10. Eur J Neurosci 13:493-502.
29. Molina-Holgado E, Vela JM, Arévalo-Martín A, Molina-Holgado F, Almazán G, Borrell J, Guaza C (2002) Expression of cannabinoid CB1 receptors in oligodendroglial cells: activation of PI-3K/Akt signaling pathway promotes cell survival. J Neurosci 22:9742-9753.
30. Molina-Holgado F, Lledo A, Guaza C (1997) Anandamide suppresses nitric oxide and TNF-α responses to Theiler's virus or endotoxin in astrocytes NeuroReport 8:1929-1933.
31. Molina-Holgado F, Molina-Holgado E, Guaza C, Rothwell N (2002) Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide induced nitric oxide release in astrocyte cultures. J Neurosci Res 67:829-836.
32. Munro S, Thomas KL, Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365:61-65.
33. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG (2000) Multiple sclerosis. N Engl J Med 343:938-952.
34. Pertwee RG (1999) Pharmacology of cannabinoid receptor ligands. Curr Med Chem 6:635-664.
35. Pertwee RG (2002) Cannabinoids and multiple sclerosis. Pharmacol Ther 95:165-174.
36. Piomelli D, Giuffrida A, Calignano A, Rodriguez de Fonseca F (2000) The endocannabinoid system as a target for therapeutic drugs. Trends Pharmacol Sci 21:218-224.
37. Puffenbarger RA, Boothe AC, Cabral GA (2000) Cannabinoids inhibit LPSinducible cytokine mRNA expression in rat microglial cells. Glia 29:58-69.
38. Warrington AE, Asakura K, Bieber AJ, Ciric B, Van Keulen V, Kaveri SV, Kyle RA, Pease LR, Rodríguez M (2000) Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis. Proc Natl Acad Sci USA 97:6820-6825.
39. 9-Tetrahydrocannabinol induces apoptosis in macrophages and lymphocytes: involvement of bcl-2 and caspase-1. J Pharmacol Exp Ther 286:1103-1109.